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Orthopaedic surgeons and scientists recognize infection as one of the most
serious and distressing complications of orthopaedic procedures. While the
incidence of infection is relatively low in elective procedures at 1e2%, the
risk of infection increases dramatically for traumatic procedures with an
estimated 27% incidence in civilians and 40% incidence in war injuries.
Approximately 112,000 orthopaedic device-related infections occur every
year in the US alone with an estimated increase in hospital costs of
$15,000e30,000 per incident. Infection has therefore made a serious
resurgence as a major complication of orthopaedic trauma and reconstruc-
tion surgery. The combination of patient related factors and multidrug
resistant organisms creates a serious challenge to treating surgeons.
In spite of substantial advances in research and development including
improvement in medical and surgical practices, bone and bone-associated
infections are still very difficult to diagnose, prevent and decisive treatment
often requires surgical removal of the implant. The most pressing issues in
this field involve the requirement for sensitive and specific infection
diagnostics and improved antimicrobial intervention strategies. AOTrauma,
a clinical division of the AO Foundation acknowledged the challenge posed
by bone infection and defined it as the focus of a new Clinical Priority
Program (CPP). This aims of the new CPP are to: (1) achieve a better un-
derstanding of bone infection; (2) provide solutions for this very pressing
clinical problem; (3) have a positive impact on patient care.
It is the purpose of this workshop to present the latest advances in the
preclinical and clinical research of bone infections and describe
developments in clinically relevant animal models required for the testing of
these urgently required solutions to the infection problem.i.org/10.1016/j.jot.2016.05.005SpeakersSpeaker 1: Introduction to AOTrauma Clinical Priority
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